Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
IPO
Common Stock
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2018 $ 5,129   $ 15   $ 148,641   $ (143,527)
Balance, shares at Dec. 31, 2018     15,591,357        
Beginning balance adjustment – impact of ASC 606 3,115           3,115
Issuance of common stock, net of issuance costs 1,604 $ 36,849 $ 1 $ 4 1,603 $ 36,845  
Issuance of common stock, net of issuance costs, shares     227,628 4,297,901      
Issuance of common stock upon exercise of stock options 55       55    
Issuance of common stock upon exercise of stock options, shares     72,034        
Exercise of warrants 23       23    
Exercise of warrants, shares     155,338        
Taxes paid on RSA (1,897)       (1,897)    
Employee and nonemployee stock-based compensation 5,604       5,604    
Net loss (10,723)           (10,723)
Balance, at end of period at Jun. 30, 2019 39,759   $ 20   190,874   (151,135)
Balance, shares at Jun. 30, 2019     20,344,258        
Balance, beginning of period at Dec. 31, 2018 5,129   $ 15   148,641   (143,527)
Balance, shares at Dec. 31, 2018     15,591,357        
Balance, at end of period at Dec. 31, 2019 25,525   $ 20   191,751   (166,246)
Balance, shares at Dec. 31, 2019     20,437,235        
Balance, beginning of period at Mar. 31, 2019 4,812   $ 16   150,322   (145,536)
Balance, shares at Mar. 31, 2019     15,873,705        
Issuance of common stock, net of issuance costs   $ 36,849   $ 4   $ 36,845  
Issuance of common stock, net of issuance costs, shares       4,077,143      
Net issuance of restricted stock award (RSA), shares     220,758        
Issuance of common stock upon exercise of stock options 14       14    
Issuance of common stock upon exercise of stock options, shares     17,314        
Exercise of warrants 23       23    
Exercise of warrants, shares     155,338        
Taxes paid on RSA (1,897)       (1,897)    
Employee and nonemployee stock-based compensation 5,557       5,557    
Net loss (5,599)           (5,599)
Balance, at end of period at Jun. 30, 2019 39,759   $ 20   190,874   (151,135)
Balance, shares at Jun. 30, 2019     20,344,258        
Balance, beginning of period at Dec. 31, 2019 25,525   $ 20   191,751   (166,246)
Balance, shares at Dec. 31, 2019     20,437,235        
Issuance of common stock, net of issuance costs 24,992   $ 37   24,955    
Issuance of common stock, net of issuance costs, shares     36,800,000        
Issuance of common stock, debt repayment 6,001   $ 8   5,993    
Issuance of common stock, debt repayment, shares     8,226,834        
Issuance of common stock upon exercise of stock options $ 303   $ 1   302    
Issuance of common stock upon exercise of stock options, shares 363,857   363,857        
Issuance of common stock upon exercise of ESPP $ 42       42    
Issuance of common stock upon exercise of ESPP, shares     64,320        
Net settlement of common stock upon release of RSU (6)       (6)    
Net settlement of common stock upon release of RSU, shares     35,070        
Employee and nonemployee stock-based compensation 458       458    
Net loss (17,060)           (17,060)
Balance, at end of period at Jun. 30, 2020 40,255   $ 66   223,495   (183,306)
Balance, shares at Jun. 30, 2020     65,927,316        
Balance, beginning of period at Mar. 31, 2020 15,994   $ 21   192,183   (176,210)
Balance, shares at Mar. 31, 2020     20,677,360        
Issuance of common stock, net of issuance costs 24,992   $ 37   24,955    
Issuance of common stock, net of issuance costs, shares     36,800,000        
Issuance of common stock, debt repayment 6,001   $ 8   5,993    
Issuance of common stock, debt repayment, shares     8,226,834        
Issuance of common stock upon exercise of stock options 93       93    
Issuance of common stock upon exercise of stock options, shares     119,942        
Issuance of common stock upon exercise of ESPP 42       42    
Issuance of common stock upon exercise of ESPP, shares     68,110        
Net settlement of common stock upon release of RSU (6)       (6)    
Net settlement of common stock upon release of RSU, shares     35,070        
Employee and nonemployee stock-based compensation 235       235    
Net loss (7,096)           (7,096)
Balance, at end of period at Jun. 30, 2020 $ 40,255   $ 66   $ 223,495   $ (183,306)
Balance, shares at Jun. 30, 2020     65,927,316